b r i e f c o m m u n i c a t i o n s
Heterotaxy results from a failure to establish normal left-right asymmetry early in embryonic development. By whole-exome sequencing, whole-genome sequencing and high-throughput cohort resequencing, we identified recessive mutations in MMP21 (encoding matrix metallopeptidase 21) in nine index cases with heterotaxy. In addition, Mmp21-mutant mice and mmp21-morphant zebrafish displayed heterotaxy and abnormal cardiac looping, respectively, suggesting a new role for extracellular matrix remodeling in the establishment of laterality in vertebrates.
Initiation of left-right asymmetry involves the generation of leftward fluid flow by motile cilia of the embryonic node, leading to activation of the conserved NODAL gene expression cascade in the left lateral plate mesoderm and, ultimately, to the asymmetric positioning of the heart and other visceral organs 1 . Heterotaxy (or situs ambiguus) comprises the abnormal left-right positioning of visceral organs 2 , phenotypically falls between the two extremes of situs solitus (normal) and situs inversus (the complete mirror image of normal), and is often associated with complex congenital heart defects (CHDs) 1 . Laterality defects (heterotaxy and situs inversus) have an estimated prevalence of 1.1/10,000 live births 3 and account for approximately 3% of all CHDs 1 . Situs inversus can occur in the context of primary ciliary dyskinesia (PCD; MIM 244400), caused by mutations affecting structural components of motile cilia. Genes implicated in isolated heterotaxy include components of the NODAL pathway and ZIC3 (Supplementary Table 1) ; however, these genes account for only a small proportion of cases.
We investigated two non-consanguineous families with recurrent heterotaxy, with features including CHDs but without any obvious symptoms of ciliopathy. Family 1 consisted of affected dizygotic twins, one of whom died at 1 d of life from hemodynamic failure, and family 2 consisted of two affected brothers ( Fig. 1 and Supplementary Table 2 ; for further details on family 2, see ref. 4) . Whole-exome sequencing of the affected twins from family 1 (Supplementary Table 3 ) led to the identification of rare, compound heterozygous mutations in MMP21 (NM_147191.1: c.677T>C, p.Ile226Thr and c.1203G>A, p.Trp401*; the latter corresponds to rs137955225, with an allele frequency in the Exome Aggregation Consortium (ExAC) of <1/30,000 chromosomes). No rare, damaging variants were identified in genes previously implicated in isolated heterotaxy (Supplementary Table 1 ). Point mutations were verified by Sanger sequencing, and segregation analysis indicated recessive inheritance (Fig. 1) . On the basis of previous whole-genome sequencing of the affected brothers from family 2 and their healthy parents, compound heterozygous missense variants in BCL9L were suggested as potentially pathogenic 4 ; however, both BCL9L variants in the family were predicted to be benign and neutral by the PolyPhen-2 and PROVEAN programs, respectively, and left-right patterning defects have not been reported in Bcl9l-knockout mice or bcl9l -morphant zebrafish 5, 6 . Reanalysis of the whole-genome sequencing data from family 2 for the identification of structural variants found compound heterozygosity in both brothers for a deletion of exons 1-3 of MMP21 (chr. 10: 127,460,915-127,466,819; Supplementary Fig. 1 ) inherited from the mother and a frameshift mutation in MMP21 (c.365delT, p.Met122Serfs*55) inherited from the father. The heterozygous exonic deletion was validated by microarray analysis, and its breakpoints were verified by long-range PCR and Sanger sequencing.
Subsequently, we sequenced MMP21 after HaloPlex target enrichment in 264 index cases with either heterotaxy (extracardiac and/or cardiac laterality defects such as dextrocardia or transposition of the great arteries (TGA); n = 154) or non-heterotaxy CHDs such as isolated tetralogy of Fallot or common arterial trunk (n = 110). The total MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates series included 25 syndromic cases in which heterotaxy or CHDs were associated with one or more other anomalies (for example, anal atresia, vertebral anomalies or cleft palate) and comprised 117 familial and 147 sporadic cases, with 34 index cases born to consanguineous parents. We identified nine cases (families 3-11) with rare, biallelic MMP21 variations predicted to affect protein function; all variations were confirmed by Sanger sequencing and segregated with heterotaxy or other laterality defects and complex CHDs (Fig. 1, Supplementary Figs. 2 and 3 , and Supplementary Tables 2 and 4). For families 10 and 11, one of the variants identified in each family has been reported in the ExAC database in a homozygous state; the MMP21 variants are therefore unlikely to be causal in these cases. In families 3-9, all variants identified have ExAC allele frequencies <1/10,000 and have not been reported in a homozygous state. All missense variants (except p.Arg408Gly) were predicted to be probably damaging and deleterious by PolyPhen-2 and PROVEAN, respectively (Supplementary Table 2 ). Parametric genome-wide linkage analysis performed on families 6 and 7 (analyzed simultaneously) demonstrated a linkage peak with a logarithm of odds (LOD) score of 3.508 on a region of chromosome 10 containing MMP21 ( Supplementary Fig. 4) ; no other genes in this interval are known to cause laterality disorders (Supplementary Table 5 ). Moreover, homozygosity mapping in family 7 indicated that MMP21 falls within a large region of homozygosity shared by the two affected individuals (Supplementary Fig. 5 ). Five families were consanguineous (families 3 and 5-8). Of the three individuals from family 8 with a homozygous MMP21 variant, F8-III:9 had situs inversus totalis whereas F8-III:3 was reported to be asymptomatic, suggesting possible incomplete penetrance in this family (Fig. 1a) . Overall, the penetrance of laterality defects in our series was very high in comparison to that observed for PCD (~50%). On the basis of the above findings, MMP21 mutations account for 5.9% of non-syndromic heterotaxy cases.
MMP21 protein is predicted to be secreted and conforms to the basic domain structure of matrix metalloproteinases (MMPs) 7, 8 , comprising an N-terminal signal peptide, an autoinhibitory prodomain, a catalytic peptidase domain and four C-terminal hemopexin repeats that are involved in substrate recognition (Fig. 1b) . Mapping of the affected MMP21 peptidase domain residues Glu215, Ile226 and Ala321 to a model based on the crystal structure of the MMP11 peptidase domain indicated that all three residues fall within core components of secondary structure ( Supplementary Fig. 6 ); substitutions at these residues may therefore destabilize the domain. The p.Arg360Cys, p.Arg375His and p.Arg408Gly variants map to the first and second hemopexin domains and therefore may influence substrate specificity.
Whole-mount in situ hybridization for mmp21 in zebrafish embryos at developmental stages during which left-right asymmetry is established indicated that expression was restricted to Kupffer's vesicle (the left-right organizer in fish; Fig. 2a-e) . Injection of splice-blocking (MO1; Supplementary Fig. 7 ) or translation-blocking (MO-AUG) mmp21 morpholinos but not standard control or 5-bp mispair morpholinos resulted in randomized heart looping in zebrafish at 48 hours post-fertilization (h.p.f.) (Fig. 2f,g ). Defects in other organs known to be dependent on ciliary function were not observed (Supplementary Table 6 ), confirming a highly specialized role for mmp21 in the generation of left-right asymmetry. Tables 7-9 and accompanying manuscript 10 ). We performed CRISPR/Cas9-mediated genome editing in mouse zygotes to introduce missense mutations corresponding to the ones identified in patients from families 1 and 6 encoding p.Ile226Thr and p.Ala321Pro substitutions, respectively. We collected 49 F 0 embryos at embryonic day (E) 13.5 and observed mutations (including deletions and insertions) in Mmp21 in 15 of 15 (100%) and 20 of 34 (59%) of the embryos injected with oligonucleotides corresponding to p.Ile226Thr and p.Ala321Pro, respectively (Supplementary Fig. 8 and Supplementary Tables 10 and 11). Phenotyping showed that 97% of the mutation-positive embryos (32/33; excluding two mutation-positive dead embryos whose phenotype could not be analyzed) had CHDs including TGA, with 20 (61%) exhibiting situs inversus or heterotaxy and 13 (39%) exhibiting situs solitus ( Fig. 2h-n Deletion exons 1-3 (del ex) c.365delT, p.Met122Serfs*55 
Consistent with the above findings, two N-ethyl-N-nitrosourea (ENU)-induced Mmp21 missense mutations cause laterality defects and complex CHDs in mice 9 (Supplementary
wild-type genotypes and in one mutation-positive embryo (A321P-20). For embryo I226T-1, subcloning of the PCR products amplified from yolk sac genomic DNA showed that this embryo harbored a loss-of-function deletion on one allele and had the desired A>G mutation causing the homologous p.Ile226Thr substitution on the other allele ( Supplementary Fig. 8 and Supplementary  Table 11 ). This embryo exhibited situs inversus with CHD ( Fig. 2i and Supplementary Table 10) , and embryos I226T-4 and I226T-5 also harbored laterality defects and CHDs and had a high abundance of subclones with the knock-in allele (Supplementary Table 11 ), supporting the pathogenicity of the p.Ile226Thr missense variant. No knock-in alleles corresponding to p.Ala321Pro were identified. The above findings show that loss of Mmp21 function can cause the same spectrum of phenotypes seen in mice with ENU-induced missense mutations, suggesting that the latter result in loss of function.
Specific extracellular matrix (ECM) molecules have various roles at the embryonic node during left-right patterning 11 , suggesting candidate MMP21 cleavage targets. Also, relevant to the central role of transforming growth factor (TGF)-β family members (for example, NODAL and LEFTY) in the generation of left-right asymmetry, MMPs can activate latent TGF-β factors 12 . Important future work will involve the investigation of MMP21 cleavage targets at the node. Interestingly, an MMP21 ortholog appears to be either absent or undergoing decay in the genomes of birds, reptiles and cetartiodactyl mammals (Supplementary Figs. 9-11) . It has been reported that, in chick and pig (a cetartiodactyl), cells of the embryonic node are covered by endoderm, such that asymmetry would be established by rotational cell movements around the node rather than by ciliadriven fluid flow 13 . We speculate that MMP21 is only required in those species in which asymmetry depends on ciliated nodal cells being exposed to an extracellular cavity.
In conclusion, our results suggest that MMP21 has an essential role in the pathway specifying left-right asymmetry by providing highly specific cleavage activity at the embryonic node and that MMP21 mutations are a relatively frequent cause of heterotaxy in humans. 
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Whole-exome sequencing. For whole-exome sequencing of family 1 individuals F1-II:3 and F1-II:4, Agilent SureSelect libraries were prepared from 3 µg of genomic DNA sheared with a Covaris S2 Ultrasonicator as recommended by the manufacturer. Exome capture was performed with 51Mb Agilent SureSelect Human All Exon kit V5. Paired-end sequencing (75-bp + 75-bp reads) was carried out on a pool of barcoded exome libraries using a HiSeq 2500 instrument (Illumina). After demultiplexing, paired-end sequences were mapped to the human genome (NCBI Build 37/hg19) using Burrows-Wheeler Aligner. The mean depth of coverage obtained for the two family 1 samples was 107-and 110-fold, with 98% of the exome covered by at least 15-fold. Downstream processing was performed using the Genome Analysis Toolkit (GATK), SAMtools and Picard, and variant calls were made with the GATK UnifiedGenotyper. We removed from consideration all calls with read coverage of twofold or less or a Phred-scaled SNP quality score of 20-fold or less. Variant annotation was based on Ensembl release 71, and filtering was performed with in-house software, using the following SNP databases for filtering: dbSNP (build 135), Exome Variant Server (release ESP6500SI-V2), 1000 Genomes Project (released 21 May 2011) and a database of variants from more than 5,000 in-house exomes. Whole-exome sequencing was performed in accordance with approved institutional protocols (Comité de Protection des Personnes Ile-de-France II), and informed consent was obtained for genetic testing.
Whole-genome sequencing. Study participants. Family 2 individuals F2-I:1, F2-I:2, F2-II:3 and F2-II:4 were enrolled in the Center for Pediatric Genomic Medicine research repository and received whole-genome sequencing to diagnose suspected monogenic diseases of unknown etiology in affected children 4, 14 . The study was approved by the institutional review board at Children's Mercy Hospital, Kansas City. Library preparation and sequencing. Genomic DNA was isolated and prepared for whole-genome sequencing with a modification of the Illumina TruSeq sample preparation protocol 4, 14 . Briefly, 500 ng of DNA was sheared with a Covaris S2 Biodisruptor, end repaired, A tailed and ligated to adaptors. PCR was omitted. Libraries were purified with SPRI beads (Beckman Coulter). Quantification was carried out by RT-PCR. Libraries were denatured with 0.1 M sodium hydroxide and diluted to a concentration of 2.8 pM in hybridization buffer. Samples were each loaded onto two flow cells, followed by 2 × 100 cycle sequencing on Illumina HiSeq 2500 instruments.
Next-generation sequencing analysis. Sequence data were generated with Illumina RTA 1.12.4.2 and CASAVA-1.8.2 and aligned to human reference genome GRCh37.p5 using the Genomic Short-Read Nucleotide Alignment Program (GSNAP). Deletion variants were identified with a novel computational pipeline (Screening Konsensus and Annotation of Large Deletions (SKALD); A.N. and S.F.K., unpublished data). Briefly, SKALD starts from a GSNAP-derived bam file, executes the structural variant detection tools BreakDancer 15 and GenomeStrip 16 concurrently, and applies filters (ratio of depth within the structural variant to depth for the region flanking the structural variant ≤0.7, GenomeStrip confidence interval ≤40, BreakDancer score ≥30, deletion size ≤0.5 Mb, supporting 'stretched' read pairs ≥2, overlapping repeat features ≤1,500) to yield a high-confidence deletion variant set. Because genes that are commonly deleted are unlikely to be deleterious, only deletion variants harboring rarely deleted genes were retained. Nucleotide variants were detected and genotyped with GATK v.1.4 and annotated with RUNES 4, 14 . Likely pathogenic hemizygous nucleotide variants were sought within the boundaries of deletion variants by limitation to rare coding and splicing variants with allele frequency <1% in an internal database 4, 14 and were included as part of the SKALD output in the form of a tab-separated txt file. Variant analysis programs were either written in Perl, R, Make or the Linux shell scripting language. Variant statistics from the whole-genome sequencing of family 2 have previously been published (see data for individuals CMH184, CMH185, CMH186 and CMH202 in ref. 4 ).
Microarray analysis. For validation of the deletion identified by wholegenome sequencing in family 2, genomic DNA was isolated using the Gentra PureGene kit for whole blood. Test sample DNA was hybridized to Affymetrix CytoScan HD CN+SNP microarray chips. The chips were washed, stained and scanned. Raw cel and dat files were converted to cychp files using CytoScan HD Array Chromosome Analysis Suite 2.0. NetAffx 32.3 (hg19) was used for final analysis and the exporting of deletion calls.
HaloPlex sequencing. DNA extraction, quantification, quality control and pooling. The study protocol was approved by the local institutional review board (Comité de Protection des Personnes Sud-Est II), and signed informed consent was obtained from all participants (or from the parents of minors or fetuses). DNA was extracted from either whole blood or fetal tissue using a variety of extraction protocols. DNA concentration and quality were assessed using NanoDrop (Thermo Scientific) and Qubit (Life Technologies) fluorometers. A260/A280 ratios of 1.8 to 2.0 and A260/A230 ratios >1.5 were accepted. DNA fragmentation was assessed using agarose gel (0.8%) electrophoresis. Pools of six DNA samples each were prepared by combining DNA extracted using the same protocol.
HaloPlex design. The seven exons together with the 25 intronic nucleotides flanking each exon of the unique MMP21 transcript (ENST00000368808; NM_147191.1, GRCh37) and the corresponding sequences for two other genes (total target region, 5,624 nucleotides; total target region for MMP21, 2,060 nucleotides) were selected to generate probes according to SureDesign with a predicted MMP21 sequencing coverage of 99.47%.
HaloPlex library preparation. Amplicon libraries were prepared from the genomic DNA of each pool using the HaloPlex PCR target enrichment system according to the manufacturer's recommendations. In brief, 200 ng of pooled DNA (33 ng of each individual DNA) was used for restriction reactions. Successful digestion was verified on a Bioanalyzer 2100 with a high-sensitivity chip (Agilent Technologies). DNA pools were then hybridized for 3 h at 54 °C to customized, biotinylated probes in a Biometra T Professional thermocycler (Analytik Jena). Hybridized probes in the presence of the primer barcode cassette were captured with magnetic beads, and target fragments were ligated to create circular molecules. Libraries were then amplified by PCR using HaloPlex Ion primers. Libraries were quantified using a Bioanalyzer 2100 with a high-sensitivity chip. The same molar amount of each library was used to generated pools of 16 libraries (6 × 16 = 96 DNA samples) at a final concentration of 20 pM.
Sequencing, quality controls and variant calling. Sequencing was performed using an Ion PGM sequencer (Life Technologies) with Ion 318 chip v2. Pooled DNA at a 20 pM concentration (25 µl) was used for emulsion PCR. The quality of sequencing was assessed by the PGM sequencer, which determined the Ion Sphere Particle (ISP) density, number of total reads, percentage of usable reads, percentages of monoclonal and polyclonal reads, mean read lengths (AQ17, AQ20 and perfect), and percentages of low-quality sequences, adaptor dimers and aligned bases. The bam files were loaded on Alamut Visual 2.5 (Interactive Biosoftware), and variant detection was performed manually by setting the variant detection threshold to 0.04. Stop-gain, splice-site, frameshift and rare missense variants (at a frequency <0.1% in the Exome Variant Server) were selected for Sanger sequencing in the six individual DNA samples composing the pool carrying each selected variant. Variants of interest were confirmed in a second dilution of DNA and in an independent sample. Subsequently, relatives were tested for variant segregation analysis.
Genome-wide linkage analysis and homozygosity mapping. DNA was extracted from either whole blood or fetal tissue using a variety of extraction protocols. DNA concentration and quality were assessed using NanoDrop and Qubit fluorometers. A260/A280 ratios of 1.8 to 2.0 and A260/A230 ratios >1.5 were accepted. DNA fragmentation was assessed using agarose gel (0.8%) electrophoresis.
A minimum amount of each DNA sample (1 µg) at a minimal concentration of 50 ng/µl was used for genotyping on a HumanCoreExome-12 v1.0 (WG-353-1104) npg
